Deletion of myeloid IRS2 enhances adipose tissue sympathetic nerve function and limits obesity by Rached, Marie-Therese et al.
Q6
Q5
Q2
Q1
Original Article
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
MOLMET749_proof ■ 3 December 2018 ■ 1/1361
62
63
64
65
66
67
68
69Deletion of myeloid IRS2 enhances adipose
tissue sympathetic nerve function and limits
obesity70
71
72
73
74
75
76Marie-Therese Rached 1,2, Steven J. Millership 1,2, Silvia M.A. Pedroni 1,2, Agharul I. Choudhury 1,
Ana S.H. Costa 3, Darran G. Hardy 1,2, Justyna A. Glegola 1, Elaine E. Irvine 1, Colin Selman 4,
Megan C. Woodberry 1, Vijay K. Yadav 5,6, Sanjay Khadayate 1, Antonio Vidal-Puig 5,7, Samuel Virtue 7,
Christian Frezza 3, Dominic J. Withers 1,2,*77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96ABSTRACT
Objective: Sympathetic nervous system and immune cell interactions play key roles in the regulation of metabolism. For example, recent
convergent studies have shown that macrophages regulate obesity through brown adipose tissue (BAT) activation and beiging of white adipose
tissue (WAT) via effects upon local catecholamine availability. However, these studies have raised issues about the underlying mechanisms
involved including questions regarding the production of catecholamines by macrophages, the role of macrophage polarization state and the
underlying intracellular signaling pathways in macrophages that might mediate these effects.
Methods: To address such issues we generated mice lacking Irs2, which mediates the effects of insulin and interleukin 4, speciﬁcally in LyzM
expressing cells (Irs2LyzM/ mice).
Results: These animals displayed obesity resistance and preservation of glucose homeostasis on high fat diet feeding due to increased energy
expenditure via enhanced BAT activity and WAT beiging. Macrophages per se did not produce catecholamines but Irs2LyzM/ mice displayed
increased sympathetic nerve density and catecholamine availability in adipose tissue. Irs2-deﬁcient macrophages displayed an anti-inﬂammatory
transcriptional proﬁle and alterations in genes involved in scavenging catecholamines and supporting increased sympathetic innervation.
Conclusions: Our studies identify a critical macrophage signaling pathway involved in the regulation of adipose tissue sympathetic nerve
function that, in turn, mediates key neuroimmune effects upon systemic metabolism. The insights gained may open therapeutic opportunities for
the treatment of obesity.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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1071. INTRODUCTION
Obesity and its associated co-morbidities such as type 2 diabetes are
major threats to health worldwide with over 2.1 billion people currently
being classiﬁed as overweight or obese [1e3]. The pathophysiology of
obesity is increasingly thought to involve cross-talk between the im-
mune and metabolic regulatory systems [4e9]. Over-nutrition, leading
to obesity, is associated with an altered adipose tissue immune proﬁle
and inﬂammation [4,7e9]. This in turn leads to a systemic pro-
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core of obesity-associated inﬂammation [6,9]. While now recognized
as an oversimpliﬁcation, two basic polarization states of macrophages
have been deﬁned: classically activated (M1) macrophages (CAM) have
a pro-inﬂammatory phenotype while alternatively activated (M2)
macrophages (AAM) have an anti-inﬂammatory phenotype [10,11].
The distinct physiological roles of these macrophage phenotypes are
reﬂected in the pathogenesis of obesity which is associated with
increased adipose tissue M1 macrophage inﬁltration and release of
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MOLMET749_proof ■ 3 December 2018 ■ 2/13[7,8,12]. In contrast, AAM can mitigate against insulin resistance with
improved insulin sensitivity associated with increased numbers of AAM
in adipose tissue [7e9]. Macrophage polarization status is under
complex regulation with interferon gamma, for example, promoting the
generation of CAM/M1 macrophages while interleukins (IL) IL4/IL13
promote the AAM/M2 phenotype [13,14]. IL4/IL13 may play a role in
metabolic homeostasis [13]. For example, maintenance of AAMs in
white adipose tissue (WAT) depends on IL4/13 signaling to STAT6
[13,15] and this pathway also programs macrophage metabolism via
PPARG, PPARD, and PGC1B away from the anaerobic metabolic proﬁle
seen in CAM [13,16]. IL4 signaling in macrophages has also been
proposed to regulate BAT thermogenesis as acute cold stress causes
AAM themselves to produce catecholamines in an IL4-dependent
manner, leading to BAT browning and the biogenesis of beige fat in
WAT depots [17]. Consistent with these observations, IL4 adminis-
tration to mice provided protection from obesity-associated insulin
resistance [17]. However, these ﬁndings have been called into ques-
tion by a recent study that failed to conﬁrm that AAM synthesize
catecholamines or regulate adaptive thermogenesis and did not
demonstrate beneﬁcial metabolic effects of IL4 administration to mice
[18]. In contrast, it has been demonstrated that macrophages may
directly regulate sympathetic nervous system function in adipose tis-
sue including the regulation of browning [19,20] but the potential role
of IL4 in this process is unclear.
In macrophages, IL4 signals via either the type I receptor consisting of
IL4RA and IL4RG subunits or the type II receptor composed of IL4RA
and IL13RA1 subunits [13,21e23]. Type I and type II receptors recruit
JAK/STAT signaling with the shared IL4RA chain associating with JAK1
leading to STAT6 phosphorylation [13,21e23]. In addition, IL4RA ac-
tivates insulin receptor substrate (IRS) 2, which is also the major target
of insulin and IGF1 receptors in hematopoietic cells particularly of the
myeloid lineage [24e26]. When tyrosine phosphorylated, IRS2 recruits
the regulatory subunits of PI3K, GRB2, and other SH2 domain con-
taining molecules to activate a number of downstream signaling
pathways [27,28]. However, despite its potentially critical role in both
IL4 and insulin/IGF1 receptor signaling, the precise in vivo function of
IRS2 in macrophage biology is less clear. Deﬁning its role is compli-
cated by the observations that while IL4 signaling is primarily anti-
inﬂammatory, insulin action upon macrophages may be pro-
inﬂammatory [21,29,30]. Thus, IRS2 signaling may mediate diver-
gent biological outputs but to date the precise balance of such effects
in metabolic physiology is unknown. For example, myeloid-restricted
deletion of the insulin receptor in mice leads to improved whole ani-
mal insulin sensitivity under conditions of high fat feeding due to
reduced migration of macrophages into white adipose tissue [31]. Mice
with global deletion of Irs2 develop progressive diabetes due to a
combination of systemic insulin resistance, hypothalamic obesity and
pancreatic beta cell failure which together have precluded detailed
analysis of the speciﬁc role of macrophage IRS2 signaling in physiology
[32e34]. However, a study using transplanted bone marrow from
these animals demonstrated that insulin signaling via IRS2 in macro-
phages contributed to pro-inﬂammatory signals involved in the
development of atherosclerosis [35]. Consistent with this concept,
in vitro studies have suggested that IRS2 signaling in macrophages is
required for IL4/IL4RAemediated expression of genes characteristic of
the AAM/M2 anti-inﬂammatory phenotype [21]. However, recent
studies in Irs2-deﬁcient macrophages also demonstrated alterations in
gene expression towards an M2 phenotype with compensatory IRS1
signaling suggested to underlie this observation [29]. These ﬁndings
also indicate that IRS2 signaling might act as a restraint to IL4-2 MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier Gmediated regulation of M2 genes revealing unexpected complexities
in the underlying signaling mechanisms.
Given the key potential role of IRS2 signaling as an intersection point
between IL4 and insulin signaling in macrophage function and sys-
temic metabolism we generated mice with myeloid-restricted deletion
of Irs2. We found that macrophages from these animals showed a
broad anti-inﬂammatory phenotype when exposed to inﬂammatory
mediators but with a limited increase in the expression of markers of
the AAM/M2 phenotype. Furthermore, these animals showed improved
insulin sensitivity and a resistance to weight gain on a high fat diet
associated with increased BAT function and increased WAT browning
at ambient temperature. However, we were unable to ﬁnd evidence
that this phenotype was driven by intrinsic macrophage catecholamine
production. In contrast, we ﬁnd that macrophages associate with BAT
sympathetic nerves and that deletion of Irs2 in these cells increases
sympathetic innervation and local norepinephrine levels in BAT.
Together these studies reveal an important role for macrophage Irs2 in
systemic metabolism and reveal new details of the signaling mecha-
nisms underlying the cross-talk between the immune and nervous
system relevant to the pathogenesis of obesity and insulin resistance.
2. METHODS
2.1. Animals
Experiments involving animals were designed and reported following
the ARRIVE guidelines of animal experiment reporting [36]. Power
calculations for number of mice for each experiment were based on
reported or known effect sizes and variation, in order to maximize
chances of meaningful Results without the unnecessary use of
experimental animals. Where possible, investigators were blinded to
the genotype of both study animals and tissue/blood samples. In all
in vivo experiments, data presented were obtained from male mice
except for the HFD studies for which data from female mice are pre-
sented. BMDM studies were performed on 10-week old male mice.
Deletion of Irs2 in myeloid lineages was carried out using Cre-LoxP
technology using mice with a previously generated ﬂoxed allele of Irs2
[37] crossed with mice expressing Cre-recombinase driven by the
Lysozyme M promoter [38]. Irs2 ﬂoxed mice were backcrossed to a
C57BL/6J background whereas Lysozyme M Cre mice were on a
mixed C57BL/6J:129S2/Sv genetic background. Irs2 deletion and the
presence or absence of the Cre recombinase were determined by PCR
as described previously; the following PCR primers were used for
ampliﬁcation: Irs2 ﬂox forward: 50-ACTTGAAGGAAGCCACAGTCG-30,
Irs2 ﬂox reverse: 50-AGTCCACTTTCCTGACAAGC-30, Lysozyme M Cre
forward: 50-CCCAGAAATGCCAGATTACG-30, Lysozyme M Cre reverse:
50- CTTGGGCTGCCAGAATTTCTC-3’ [37,38].
Mice were maintained in a pathogenefree facility in individually
ventilated cages under a controlled temperature between 21 C and
23 C and a regular 12 h light/dark cycle with ad libitum access to
water and normal chow diet (11.5% energy from fat). The high fat diet
(HFD, Research Diets, D12451) contained 45.0% energy from fat while
the percentage energy from carbohydrates was less relative to the
chow diet (35.0% versus 61.6% respectively). Mouse studies were
performed in accordance to the United Kingdom Animals (Scientiﬁc
Procedures) Act (1986) and approved by Imperial College London’s
Animal Welfare and Ethical Review Body.
2.2. Metabolic studies
Total fat and lean mass from live non-anesthetized mice were deter-
mined using an EchoMRI quantitative whole-body compositionmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
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MOLMET749_proof ■ 3 December 2018 ■ 3/13analyzer (Zinsser Analytic) and mice were subsequently weighed to
determine percentage fat and lean mass per body weight. Energy
expenditure was calculated from singly-housed mice in CLAMS cages
(Columbus Instruments) at ambient temperature (22 C) for 24 h
following 24 h of an acclimatization period. Recordings were taken
every 20-mins. During energy expenditure measurement, water and
food were provided ad libitum. Assessment of food intake was per-
formed in singly housed mice for 3 consecutive experimental days after
a period of acclimatization [37].
High fat diet experiments were performed on 8-week-old control and
Irs2LyzM/ mice, which were each divided into two weight-matched
groups. Littermates of mixed genotypes were caged together and each
group maintained on either chow or HFD. Fasted glucose measure-
ments, glucose tolerance test (GTT) and insulin tolerance test (ITT)
were performed as previously described [37,39,40]. GTTs on chow diet
were performed by administering 2 g/kg of glucose per body weight
intraperitoneally (i.p.) at 9am after an overnight fast whereas GTTs on
HFD-fed mice were performed using glucose at a lower dose (1 g/kg
bodyweight). For ITTs, food was removed from mice at 8am and the
animals were injected i.p. with insulin (0.5 U/kg) at 2pm. Blood glucose
was measured at the times indicated in the ﬁgures using a Contour
glucometer (Bayer). Insulin sensitivity on HFD was assessed in 12 h-
fasted mice by the homeostatic model assessment of insulin resis-
tance (HOMA-IR) calculated as (I0 x G0)/405 where G0 is fasting blood
glucose in mg/dl and I0 is fasting insulin in mIU/ml measured simul-
taneously [41].
For insulin and leptin measurements, serum from fasted mice was
collected from tail vein bleeds into capillary tubes (Sarstedt) and spun
for 15 min at 4 C at 2000g. The serum supernatant was removed
into a new tube and stored at 80 C. Hormones were measured by
ELISA (Millipore) according to the manufacturer’s instructions. BAT
catecholamines were measured by 2-CAT (A-N) ELISA (Rocky Moun-
tain Diagnostics) according to manufacturer’s instructions. Brieﬂy, BAT
tissues were homogenized in homogenization buffer (1N HCl, 0.25M
EDTA, 1M Na2S2O5), and homogenates were collected after centrifu-
gation and stored at 80 C prior to quantiﬁcation. All samples were
normalized to total tissue protein concentration.
2.3. Histology
Interscapular BAT, perigonadal WAT (pWAT), and inguinal WAT (iWAT)
tissues were excised and ﬁxed in 10% neutral buffered formalin for
24 h. Tissues were then dehydrated in increasing ethanol concen-
trations before being embedded in parafﬁn and serially sectioned
(5 mm). Sections were deparafﬁnized with xylene and rehydrated
before being stained with hematoxylin and eosin [42].
For immunohistochemistry, iWAT sections were stained with poly-
clonal anti-UCP1 antibody (Abcam) and macrophages in pWAT were
immunostained with monoclonal rat anti-MAC2 antibody (Cedarlane
Laboratories) as described previously [43,44]. Detection was per-
formed with an HRP-conjugated secondary antibody followed by
chromogenic detection using DAB substrate. Brown and white adipose
tissue images were taken at 20x magniﬁcation using a light micro-
scope (Leica DM4000 B).
For immunoﬂuorescence staining of tyrosine hydroxylase (TH) alone or
both TH and CX3CR1 staining on BAT sections, BAT tissues were ﬁxed
with 4% paraformaldehyde (PFA) and then transferred to ethanol.
Sections were antigen retrieved by boiling in 10 mM citrate buffer, pH
6, blocked with serum-free blocking agent (Invitrogen) and sequentially
stained with rabbit anti-TH (Millipore) and rabbit polyclonal antibody to
CX3CR1 (Abcam) [45]. Secondary antibodies, goat anti-rabbit Alexa-
Fluor-488 and goat anti-rabbit AlexaFluor-568, were from Invitrogen.MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.comFor quantitative TH density analysis, a custom ImageJ macro was
written. Brieﬂy, tissue area was identiﬁed by thresholding low intensity
autoﬂuorescence signal after application of a median ﬁlter (r¼ 5), with
the image subsequently converted to a binary mask. Further binary
operations including morphological closing and dilation and ﬁll holes,
were used to accurately identify the boundaries of the total tissue area
within the image. For subsequent analysis, pixels outside the tissue
area segmented were set to zero. Identiﬁcation of the tissue area
without the inclusion of areas occupied by lipids was achieved by using
a similar method as aforementioned, however without the addition of
the further binary operations. Fluorescence from TH immunostaining
was analyzed according to these thresholds and binary operations
made accordingly. Percentage of the ﬂuorescent signal relative to the
total tissue area excluding lipids is presented as TH density.
2.4. Magnetic isolation of CD11B positive fraction from the stromal
vascular fraction of perigonadal WAT
Perigonadal white adipose tissue (pWAT) was collected from HFD-fed
mice and digested in a Hank’s Balanced Salt Solution containing BSA
and type II collagenase (SigmaeAldrich) at 37 C, 100 rpm for 20e
30 min. The ﬂoating adipocytes were separated from the stromal
vascular fraction (SVF) by centrifugation. The CD11B fraction was
extracted from the SVF pellet using CD11B microbeads (Miltenyi Bio-
tec) conjugated to monoclonal rat anti-mouse/human antibody. The
mixture of SVF/antibody was passed through a LS column (Miltenyi
Biotec) placed in a magnetic ﬁeld. CD11B positive fraction was eluted
according to the manufacturer’s instructions and then processed for
RNA extraction using the RNeasy mini kit (Qiagen) [46].
2.5. Macrophage culture and treatment
Bone marrow-derived macrophages (BMDMs) were cultured as pre-
viously described [47]. Brieﬂy, femurs and tibias were cut at the
proximity of each joint and bone marrow ﬂushed out with PBS. Cells
were then collected, centrifuged at 500g, and resuspended in
macrophage complete medium (1:1 DMEM/F12, 10% FBS, 2 mM L-
glutamine) consisting of 25% L929 conditioned-medium until full
differentiated (7e10 days). Macrophage activation was induced in
differentiated BMDMs by stimulation with bacterial lipopolysaccharide
(LPS) from Escherichia coli (100 ng/ml, SigmaeAldrich) or IL4 (10 ng/
ml, R&D Systems) for 24 h [10,21,48]. For short-term signaling
studies, BMDMs were treated with IL4 (20 ng/ml) or insulin (10 nM,
Novo Nordisk) for times indicated and homogenized in lysis buffer
(50 mM TriseHCl pH 7.5,150 mM NaCl, 1% Triton-X100, 1 mM EDTA
with Complete Mini protease inhibitors and PHOSstop phosphatase
inhibitors (both Roche)). Phosphorylation of AKT was analyzed by
western blotting from cleared lysates normalized for total protein by
BCA method (Bio-Rad) using antibodies against serine 473 phos-
phorylated AKT and pan AKT (both Cell Signaling, 9271 and 2920,
respectively). For expression of IRS1, lysates from brain tissue and
BMDM, obtained as above, were blotted using a monoclonal IRS1
antibody (Upstate, clone 4.2.2). For palmitate treatment, BMDMs were
incubated with 500 mM palmitate-BSA (Agilent technologies) for the
times indicated, with BSA treatment as a control. BMDMs were then
processed for RT-PCR studies to measure Irs2 mRNA expression as
described below.
2.6. Catecholamine measurement by LC/MS
500,000 cells were seeded in 6-well plates and treated for 24 h with
either IL4 or LPS. Control (non-conditioned) and BMDM-conditioned
medium was collected from each well, centrifuged at 16,000g for
10 min at 4 C and 50 ml of the supernatant were added to 750 ml ofpen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 3
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MOLMET749_proof ■ 3 December 2018 ■ 4/13cold extraction solution (50% v/v methanol, 30% v/v acetonitrile, 20%
v/v ddH2O). Cell culture medium extracts were kept under agitation at
4 C for 15 min in a ThermoMixer (Eppendorf). Finally, the suspension
was centrifuged for 10 min at 16,000g at 4 C, the supernatant
transferred into autosampler vials and stored at 80 C until further
analysis. Liquid chromatographyemass spectrometry (LCeMS) anal-
ysis was performed on a Q Exactive mass spectrometer (Thermo Fisher
Scientiﬁc) coupled to a Dionex UltiMate 3000 Rapid Separation LC
system. The LC system was ﬁtted with a Raptor FluoroPhenyl column
(150 mm  2.1 mm, 2.7 mm) with the corresponding guard column
(both Restek). The mobile phase was composed of 0.2% formic acid in
water and methanol. The ﬂow rate was set at 400 ml min1, with a
gradient from 2% to 40% organic, and a total run time of 8 min. The
mass spectrometer was operated in full MS and positive ionization
mode. Samples were randomized, to avoid bias due to machine drift,
and blinded to the operator. The acquired spectra were analyzed using
XCalibur Qual Browser and XCalibur Quan Browser software (Thermo
Scientiﬁc) by referencing to an internal library of compounds and
synthetic standards run with the same batch as the samples.
2.7. Immunocytochemistry for IRS2 in BMDM
BMDM were plated on Matrigel-coated glass coverslips (VWR). Once
adhered, cells were ﬁxed with 100% methanol for 1 min at room
temperature. For IRS2 staining, cells were permeabilized (PBS with
0.1% Triton X-100 and 1% BSA) for 5 min. After ﬁxing and per-
meabilization, coverslips were washed (PBS) and blocked (0.5% ﬁsh
skin gelatin in PBS) overnight. Coverslips were then incubated with
rabbit polyclonal anti-IRS2 primary antibody (Upstate) for 3 h at room
temperature. Cells were washed and further incubated with goat anti-
rabbit AlexaFluor-488 secondary antibody (Invitrogen) for 30 min in the
dark. Cover slips were washed with PBS to remove unbound secondary
antibody and mounted with Vectashield mounting medium with DAPI
(Vector labs) on glass slides, immobilized with clear nail polish, and
visualized using a Leica SP5 confocal microscope.
2.8. mRNA expression analysis and RNA sequencing
RNA was extracted from snap-frozen tissues and BMDM using TRIzol
reagent (SigmaeAldrich) followed by chloroform treatment, and iso-
propanol to precipitate RNA. Following centrifugation, the pellet was
washed with 70% ethanol, dried and resuspended in RNase-free H2O.
RNA quality and quantity were assessed using a ND-1000 spectro-
photometer Nanodrop (Thermo Fisher Scientiﬁc) for real-time PCR (RT-
PCR) purposes and a Bioanalyzer 2100 (Agilent) for mRNA sequencing
purposes. RNA from the cell pellet collected from CD11B positive
fractions was isolated using RNeasy spin columns (Qiagen).
Total RNA was treated with DNase I (Qiagen) and 1 mg was reverse
transcribed at 42 C with SuperScript II (Invitrogen). Quantitative PCR
reactions were carried out in duplicate on 384-well clear optical plates
using a Taqman ABI 7900HT fast real-time PCR machine equipped
with SDS 2.3 software. A list of all probes is presented in Supplemental
Table 1. Experimental Ct values were normalized to speciﬁc house-
keeping genes. A relative quantiﬁcation using the DCT method or an
absolute quantiﬁcation using the standard curve method were used as
appropriate as indicated in ﬁgure legends. Hypoxanthine phosphor-
ibosyltransferase (Hprt) was the housekeeping gene used to normalize
Ct values in macrophages. Hprt Ct values were stable across BMDM
and ATM samples of both genotypes and upon IL4 and LPS treatments.
To quantify mRNA in adipose tissues, the housekeeping gene Gapdh
(glyceraldehyde 3 phosphate dehydrogenase) was used.
For RNA sequencing analysis, the standard Illumina library preparation
protocol was carried out on 2 mg of RNA and the library prepared using4 MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier Gthe TrueSeq kit (Illumina) according to manufacturer’s protocol. Each
sample was divided into 8 technical replicates and sequenced on in-
dividual lanes in an Illumina ﬂow cell. The sequencing was performed
using standard Illumina protocols at the Sanger institute. Raw reads
from the sequenced RNAseq libraries were mapped with Tophat splice
junction aligner [49], version 2.0.8 against Ensembl mouse genome
reference sequence assembly (mm9) and transcript annotations. All
parameters were set to default except inner distance between mate
pairs (r ¼ 130).
Gene-based read counts were then obtained using the HTSeq count
module (version 0.5.4p3) [50]. This HTSeq counts module was run
using parameters m ¼ intersection-nonempty, stranded ¼ no. Dif-
ferential expression analysis was performed on the counts data using
the DESeq2 Bioconductor package (version 1.16.1) [51]. This DESeq2
package uses negative binomial model to model read counts and then
performs statistical tests for differential expression of genes. Raw P
values were then adjusted for multiple testing with the Benjamini-
Hochberg procedure. Genes with adjusted P value of 0.05 or less
were termed as differentially expressed genes.
Geneset enrichment analysis was performed to elucidate biological
pathways and processes regulated by the interaction between
Irs2LyzM/ and control BMDM and with various treatments (IL4, LPS).
The GSEA [52] preranked tool from GSEA version 2.2.4 was used for
this purpose. Gene ontology enrichment analysis was also performed
using the topGo Bioconductor package [53] separately for up and
down-regulated genes in the comparisons analyzed.
2.9. Statistics
Statistical analysis was carried out using Prism 7 software. Student’s t
test or ANOVA (or ManneWhitney U or KruskaleWallis tests) were
used where data was parametric or nonparametric, respectively. A P
value less than 0.05 was considered signiﬁcant where * represents
P < 0.05, **p < 0.01 and ***p < 0.001. In all panels, data are
represented as mean  SEM unless otherwise stated. For energy
expenditure (CLAMS) data on HFD, a general linear modeling (GLM) in
SPSS was used with genotype as a ﬁxed factor, body weight as co-
variate and energy expenditure as the dependent variable.
3. RESULTS
3.1. Loss of Irs2 in myeloid cells improves glucose homeostasis
and promotes resistance to high fat diet induced metabolic
dysfunction
To investigate the role of macrophage IRS2 signaling in metabolism,
we conditionally deleted Irs2 in myeloid cells in mice. To achieve this,
we generated mice homozygous for a ﬂoxed allele of Irs2 [37] and
heterozygous for a transgene expressing Cre recombinase from the
LyzM locus (Irs2ﬂ/ﬂLyzM-Cretg/wt termed Irs2LyzM/ hereafter) [38]. A
combination of pure WT, Irs2ﬂ/ﬂ and LyzM-Cretg/wt which were
phenotypically indistinguishable served as controls. We conﬁrmed
efﬁcient deletion of Irs2 in bone-marrow derived macrophages (BMDM)
by analyzing mRNA expression levels in Irs2LyzM/ mice and control
mice by RT-PCR. (Supplemental Fig. 1A). To conﬁrm loss of IRS2
protein expression, we performed immunoﬂuorescence staining in
control BMDM and those derived from Irs2LyzM/ mice (Irs2/
BMDMs). This showed cytoplasmic staining for IRS2 in control BMDM
and a complete absence of IRS2 in Irs2/ BMDMs (Supplemental
Fig. 1B).
Next, we studied the body weight and metabolic phenotypes of
Irs2LyzM/ mice on a normal chow diet. At 23 weeks of age we saw
no signiﬁcant difference in body weight between control and Irs2LyzM/mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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MOLMET749_proof ■ 3 December 2018 ■ 5/13mice of either sex (Supplemental Fig. 1C). Assessment of percentage
fat mass vs body weight by EchoMRI at earlier ages showed no dif-
ferences between control and Irs2LyzM/ mice (control: 10.5  1.3%
vs. 12.7  1.4% in Irs2LyzM/ mice, n ¼ 8, P ¼ 0.267). However,
when energy expenditure was assessed by indirect calorimetry, 8-
week old male Irs2LyzM/ mice displayed signiﬁcantly increased EE
in both light and dark cycles (Figure 1A). Mice at this age showed a
compensatory increase in food intake on a chow diet (control:
0.199  0.007 g/g/day vs. 0.229  0.008 g/g/day in Irs2LyzM/
mice, n ¼ 10, P ¼ 0.011) similar to that seen in other mouse models
with increased EE such as cold exposed mice [54] or mice with genetic
interventions elevating EE (e.g. [55]). By 23 weeks of age male
Irs2LyzM/ mice showed a signiﬁcant reduction in fat mass
(Figure 1B) with a concomitant increase in lean body mass (Figure 1C)
We next assessed glucose homeostasis in chow fed-Irs2LyzM/ mice.
At 8e10 weeks of age Irs2LyzM/ mice had a signiﬁcant reduction in
both fasting glucose and insulin levels (Figure 1D, E). This was
accompanied by a mild improvement in glucose clearance and insulin
sensitivity (Figure 1F and ITT AUC e control: 6611  311 vs.
5618  225 in Irs2LyzM/ mice, n ¼ 8, P ¼ 0.043). Taken together,Figure 1: Physiological parameters in Irs2LyzML/L mice fed chow or HFD. (A) Energy
night cycles (n ¼ 22e26). (B, C) Percentage fat mass (B) and percentage lean mass (C) in
glucose levels in 8-week old control and Irs2LyzM/ female mice following an overnight f
mice following an overnight fast (n ¼ 12e20). (F) Glucose tolerance in overnight fasted 8
under the curve (AUC) for both genotypes. (G) Body weight of control and Irs2LyzM/- femal
for chow and n ¼ 23 for HFD). (H, I) Percentage fat mass (H) and percentage lean mass (I)
Serum leptin levels following an overnight fast in control and Irs2LyzM/ female fed HFD fo
in 23-week old control and Irs2LyzM/ females fed HFD for 15 weeks (n ¼ 18e20). (L, M
and Irs2LyzM/ females fed HFD for 8 weeks (n ¼ 20e23). (N) Glucose tolerance in 6
(n ¼ 21). Inset shows means of area under the curve (AUC) for both genotypes. (O) Homeo
glucose and serum insulin levels from mice in L and M (n ¼ 20). In all panels, data present
with repeated measure was used. (*P < 0.05, **P < 0.01 and ***P < 0.001 relative to
MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.comthese data suggest that deletion of Irs2 in myeloid cells leads to a mild
beneﬁcial metabolic phenotype on a chow diet associated with
increased energy expenditure.
To assess the impact of these phenotypic changes under conditions of
over-nutrition, we studied 8-week-old mice exposed to high fat diet
(HFD) for 15 weeks. Control animals gained signiﬁcantly more body
weight on HFD compared to chow but in contrast Irs2LyzM/ mice
displayed partial resistance to weight gain (Figure 1G). Consistent with
this observation Irs2LyzM/ mice had reduced percentage fat mass,
increased percentage lean mass and, as an indirect measure of body
fat, reduced leptin levels (Figure 1HeJ). Irs2LyzM/ mice also dis-
played increased energy expenditure on HFD, when corrected for
differences in body weight (Figure 1K). These increases in energy
expenditure in Irs2LyzM/ mice were also statistically signiﬁcant in
both the day (P ¼ 0.007) and night (P ¼ 0.003) cycles when using
GLM (see methods 2.9) to demonstrate that genotype is a statistically
signiﬁcant independent contributing factor to the observed difference
in EE, even after appropriately correcting for the effect of bodyweight.
Assessment of glucose homeostasis in HFD-fed Irs2LyzM/ mice
showed that these animals had lower fasting glucose and insulin levelsexpenditure (EE) in 8-week old control and Irs2LyzM/ males during both the day and
23 weeks old control and Irs2LyzM/ male mice on chow diet (n ¼ 23e24). (D) Blood
ast (n ¼ 20). (E) Serum insulin levels from 8-week old control and Irs2LyzM/ female
-week old female control and Irs2LyzM/ mice (n ¼ 8e9). Inset shows means of area
es fed either chow or high fat diet (HFD) from 8 weeks of age for 15 weeks (n ¼ 8e11
in 23-week old control and Irs2LyzM/ female mice fed HFD for 15 weeks (n ¼ 23). (J)
r 15 weeks (n ¼ 10e12). (K) Energy expenditure (EE) values normalized to body weight
) Blood glucose (L) and serum insulin levels (M) in overnight fasted 16-week old control
-hour fasted 16-week old control and Irs2LyzM/ female mice fed HFD for 8 weeks
static model assessment for insulin resistance (HOMA-IR) calculated from fasted blood
ed are mean  SEM with Student’s t test for all panels except F, G and O, where ANOVA
control mice).
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MOLMET749_proof ■ 3 December 2018 ■ 6/13and improved glucose clearance (Figure 1LeN). Insulin sensitivity as
indicated by ITT (ITT AUC on HFD e control: 10451  616, n ¼ 15 vs.
8391 615, n¼ 8 in Irs2LyzM/mice, P¼ 0.044) and HOMA-IR was
also improved compared to control mice (Figure 1O). Together these
studies show that mice lacking Irs2 in myeloid cells have partial
resistance to both HFD-induced weight gain and the associated
disruption of glucose homeostasis.
3.2. Loss of Irs2 in myeloid cells is associated with an anti-
inﬂammatory macrophage phenotype but does not alter macrophage
numbers in WAT
The beneﬁcial metabolic effects seen in Irs2LyzM/ mice on HFD
prompted us to assess whether alterations in macrophage numbers in
WAT might underlie these changes as previous studies have shown
that myeloid deletion of the insulin receptor leads to lowered inﬂam-
mation both in adipose tissue and systemically by reducing macro-
phage recruitment into WAT [31]. However, on both chow and HFD,
WAT macrophage numbers were equivalent in control and Irs2LyzM/
mice (Figure 2A). Polarization of macrophages away from a pro-
inﬂammatory CAM/M1 phenotype towards an anti-inﬂammatory
AAM/M2 phenotype also reduces adipose tissue dysfunction [56].
Therefore, we next examined the mRNA expression of candidateFigure 2: Characterization of bone marrow derived macrophages (BMDM) from Irs
number in perigonadal white adipose tissue of control and Irs2LyzM/ mice on chow (n ¼
panel, with arrows indicating the presence of macrophage crown-like structures visualized
PCR analysis of mRNA levels of M2 markers in control and Irs2LyzM/ BMDM treated wit
internal control and data are represented relative to control/vehicle (n ¼ 4e7). (FeI) Analys
24 h) (n ¼ 4e6). (J, K) Arg1 and Inos mRNA levels in control and Irs2LyzM/ adipose tissu
RT-PCR experiments and ATMs were collected from a pool of 3e6 mice on HFD in eac
mean  SEM with statistical analysis by ANOVA (AeI) or Student’s t test (J, K). (*P < 0.0
treatment).
6 MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier Gmarkers of M1/M2 polarization in BMDM isolated from control and
Irs2LyzM/ mice in response to IL4 or LPS stimulation. In response to
IL4 we found equivalent expression of Arg1 and Clec10a in Irs2-
deﬁcient BMDM and mild attenuation of the induction of Chi3l3 and
Mrc1 (Figure 2BeE). In contrast to the limited M2 changes we
detected signiﬁcant reductions in the expression of M1 markers Tnfa,
Inos, Il6, and Il1b in response to LPS in Irs2-deﬁcient macrophages,
suggesting a reduction in the pro-inﬂammatory phenotype in these
cells (Figure 2FeI). When we examined gene expression in adipose
tissue macrophages (ATM) from HFD fed mice we found increased
Arg1 expression and down-regulated Inos expression in Irs2LyzM/
mice (Figure 2J, K). Taken together, these ﬁndings suggest that deletion
of Irs2 in macrophages Results in a markedly reduced pro-inﬂammatory
response to LPS in macrophages rather than a broadly enhanced M2
proﬁle when assessed by RT-PCR. Furthermore, there were no alter-
ations in macrophage numbers in WAT upon deletion of Irs2.
3.3. Loss of Irs2 in myeloid cells is associated with increased
browning in BAT and WAT
We next undertook studies to investigate the mechanisms by which
loss of IRS2 signaling in myeloid cells might cause increased in energy
expenditure in Irs2LyzM/ mice. BAT thermogenesis has been2LyzML/L mice. (A) Quantiﬁcation of MAC2 positive cells as percentage of total cell
8e9) or high fat diet (HFD) (n ¼ 5). Representative images are shown in the right-hand
by MAC2 immunohistochemical staining. Scale bar ¼ 500 mm. (BeE) Quantitative RT-
h vehicle or interleukin 4 (IL4, 10 ng/ml, 24 h). Hprt mRNA expression was used as an
is of mRNA levels of M1 inﬂammatory markers as in B-E with LPS treatment (100 ng/ml,
e macrophages (ATM) isolated from HFD-fed mice. Data are average of two independent
h experiment (n ¼ 6e12 mice per genotype total). In all panels, data presented are
5, **P < 0.01 and ***P < 0.001, relative to control BMDM/control BMDM with vehicle
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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MOLMET749_proof ■ 3 December 2018 ■ 7/13suggested to be regulated by macrophage polarization status with M2
macrophages reported to release catecholamines in an IL4-dependent
manner [17] although these studies have been recently challenged
[18]. We found reduced lipid storage as assessed morphologically in
BAT in Irs2LyzM/ mice on both chow and HFD suggesting that there
was increased activity of BAT metabolism (Figure 3A). Consistent with
this histological ﬁnding, we found increased mRNA expression of Ucp1
and other markers of BAT activation including Cidea and Pgc1a in
Irs2LyzM/ mice on chow diet (Figure 3B). We also examined iWAT for
indications of browning in this fat depot and found increased
expression of Ucp1, Cidea and Pgc1a (Figure 3C). UCP1 protein levels
as assessed by immunostaining were also increased in iWAT of
Irs2LyzM/ mice (Figure 3D). Taken together, these observations
indicate that Irs2LyzM/ mice had upregulated BAT function and
browning of WAT.
Catecholamines play a central role in the regulation of BAT activity and
WAT browning. Therefore, we next investigated whether macrophages
per se might be a source of catecholamines underlying the increased
browning in BAT and WAT in Irs2LyzM/ mice. Initially, we used
ELISAs to measure epinephrine and norepinephrine in conditioned
medium from control and Irs2 null BMDM treated with either IL4 or
LPS, but we were unable to reliably detect these catecholamines with
these assays under these experimental conditions (data not shown).
Therefore, we used a liquid chromatography mass spectroscopy
approach to determine whether BMDM produced catecholamines.
However, we were unable to detect these species at levels above thoseFigure 3: Assessment of brown adipose tissue function in Irs2LyzML/L mice. (A) Rep
(BAT) from control and Irs2LyzM/ mice fed either chow (top panel) or high fat diet (HFD) (lo
mRNA levels of BAT genes in Irs2LyzM/ relative to control mice on chow diet. Gapdh mRN
in B of brown adipose genes in inguinal WAT (iWAT) of Irs2LyzM/ relative to control mice
Representative H&E staining (top panel) and immunostaining of UCP1 (lower panel) in
Norepinephrine levels in non-conditioned medium (Control medium) and BMDM-conditione
gland were used as a positive control (n ¼ 4 per group). (F, G) Quantitative RT-PCR analys
from control mice. Hprt mRNA expression was used as an internal control (n ¼ 7). (H) Ty
Gapdh mRNA expression was used as an internal control (n ¼ 6e8). (I, images) TH immu
visualize nuclei (blue). Scale bar ¼ 50 mm. (I, bar chart) Quantiﬁcation of percentage TH
Norepinephrine levels normalized to total protein content in BAT from control and Irs2LyzM
by Student’s t test. (*P < 0.05, **P < 0.01 and ***P < 0.001 relative to control mice).
MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.comseen in media alone under the same experimental conditions despite
being readily able to detect them in adrenal gland extracts (Figure 3E).
To further investigate these ﬁndings, we examined the expression of
the catecholamine biosynthesis enzymes Th and Dbh expression in
BMDM from control mice using RT-PCR. We validated that our primers
were functional using adrenal glands as a control but were unable to
detect any expression of catecholamine biosynthetic enzymes in
macrophages (Figure 3F, G). Taken together, these ﬁndings suggest
that macrophages are not a source of norepinephrine that might un-
derlie the upregulated BAT function and browning of WAT seen in
Irs2LyzM/ mice. Furthermore, our ﬁndings are consistent with some
recent observations showing that macrophage populations do not
express Th or produce catecholamines [18,20].
3.4. Adipose tissue macrophages associate with sympathetic
nerves: Irs2LyzM/ mice display increased density of TH-positive
neurons and elevated norepinephrine levels in BAT
Recent ﬁndings have suggested that CX3CR1-expressing macro-
phages in BAT may associate with TH-positive axons and that
macrophage-speciﬁc deletion of the transcriptional repressor Mecp2,
impairs BAT sympathetic innervation [45]. Furthermore, separate
studies have shown both ATM and a novel macrophage sub-population
(termed sympathetic-associated macrophages: SAMs) directly interact
with WAT sympathetic nerves and in part regulate adipose tissue
lipolysis by controling local catecholamine scavenging and catabolism
[20]. In our own studies, we conﬁrmed that CX3CR1-expressingresentative hematoxylin and eosin (H&E) staining of interscapular brown adipose tissue
wer panel) (n ¼ 4 per group). Scale bar ¼ 500 mm. (B) Quantitative RT-PCR analysis of
A expression was used as an internal control (n ¼ 6e8). (C) Analysis of mRNA levels as
on chow diet. Gapdh mRNA expression was used as an internal control (n ¼ 9e11). (D)
iWAT of control and Irs2LyzM/ chow-fed mice (n ¼ 4). Scale bar ¼ 500 mm. (E)
d medium (BMDM-CM) with vehicle, IL4 and LPS treatment. Lysates of mouse adrenal
is of Th (F) and Dbh (G) mRNA levels measured in BMDM relative to adrenal gland, both
rosine hydroxylase (Th) mRNA levels in BAT from Irs2LyzM/ relative to control mice.
nostaining (green) in BAT sections from control and Irs2LyzM/ mice. DAPI was used to
density in BAT sections (n ¼ 3e4 mice/group and 6e12 ﬁelds of view per mouse). (J)
/ mice (n ¼ 16). In all panels, data presented are mean  SEM with statistical analysis
pen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 7
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MOLMET749_proof ■ 3 December 2018 ■ 8/13macrophages abutted BAT TH-positive neurons (Supplemental
Fig. 1D). Furthermore, we found increased Th mRNA expression and
TH-nerve ﬁbre density in the BAT of Irs2LyzM/ mice suggesting an
increase in sympathetic innervation of BAT (Figure 3H, I). Consistent
with these observations, BAT norepinephrine levels were elevated in
Irs2LyzM/ mice (Figure 3J). Together these ﬁndings suggest that
macrophages lacking Irs2 are able to positively inﬂuence WAT/BAT
sympathetic nerve function leading to enhanced local release of
norepinephrine and increase of thermogenic capacity in adipose
tissues.
3.5. RNA sequencing analysis of Irs2-deﬁcient macrophages
reveals gene expression signatures of an anti-inﬂammatory
phenotype and increased sympathetic activity in Irs2LyzM/ mice
To try to gain broader insights into how deletion of Irs2 in macrophages
might impart a beneﬁcial metabolic phenotype and inﬂuence BATFigure 4: mRNA sequencing analysis of control and Irs2LyzML/L BMDM. (A) Heat ma
LPS treatment from RNA-seq analysis, including a large subset of downregulated pro-inﬂa
Gene ontology (GO) categories of top 200 signiﬁcantly regulated genes in Irs2LyzM/
inﬂammasome-associated genes in LPS-treated Irs2LyzM/ vs LPS-treated control BM
expression of Gdf3 in both vehicle and LPS-treated Irs2LyzM/ relative to control BMDM
categories with signiﬁcant enrichment related to nerve growth and function in Irs2LyzM/ r
Heat map showing upregulated neuronal-associated genes (secreted and cell surface pr
BMDM under various conditions. (G) GO categories with signiﬁcant enrichment in Irs2LyzM
showing increase of microglial markers in IL4-treated Irs2LyzM/ relative to IL4-treated co
treated Irs2LyzM/ relative to IL4-treated control BMDM. Log2 fold change for each gene is
categories or individual genes are shown, calculated as described in the methods (sectio
8 MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier Gfunction, we undertook RNA sequencing studies in BMDM from control
and Irs2LyzM/ mice. We focused our analysis on 1) macrophage
inﬂammatory processes that may inﬂuence the ability of macrophages
to scavenge and catabolize catecholamines as well as more broadly
inﬂuence adipose tissue function and 2) processes by which macro-
phages may inﬂuence sympathetic innervation of BAT. In BMDMs
treated with LPS, deletion of Irs2 was associated with a signiﬁcantly
reduced expression of pro-inﬂammatory gene categories as shown by
gene ontology (GO) analysis. Down-regulated GO categories included
regulation of cellular response to tumor necrosis factor, cytokine-
mediated signaling pathway, inﬂammatory response, and cellular
response to interferon beta (Figure 4A, B). Signiﬁcantly down-regulated
genes belonging to these categories included Inos, the Nfkb-related
gene Nfkbib, Tnfa, IL-related genes (Il1a, Il19, Il7r, Il15, Il10, Il1rn, Il7r,
and Il27), the Tgf beta receptor type I and a range of cytokines and
chemokines (Cxcl9, Cxcl10, Ccl2, Ccl4, Ccl5, Ccl7, Clc8, Ccrl2, andp showing differentially regulated genes in Irs2LyzM/ vs control BMDM following 24 h
mmatory genes in the Irs2LyzM//LPS group (n ¼ 4 for control, 3 for Irs2LyzM/). (B)
BMDM following 24 h treatment with LPS. (C) Differential expression of NLRP3
DM. Log2 fold change for each gene is shown in its respective bar. (D) Differential
with respective treatments. Log2 fold change is shown in each respective bar. (E) GO
elative to control BMDM with either vehicle, LPS or IL4 (overnight) treated conditions. (F)
oteins involved in cell adhesion and cell-to-cell interactions) in Irs2LyzM/ vs control
/ relative to control BMDM under various conditions. (H) Gene set enrichment analysis
ntrol BMDM. (I) Differential expression of b2 adrenergic genes Adrb2 and Adrbk2 in IL4-
shown in its respective bar. In panels BeE and also G and I, P values for GO enrichment
n 2.8).
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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MOLMET749_proof ■ 3 December 2018 ■ 9/13Ccl12 (Figure 4A, B, and Supplemental Table 2)). The expression of
genes associated with the NLRP3 inﬂammasome Ripk2, Casp1, and
Panx1 was also reduced (Figure 4C). These data indicate that deletion
of Irs2 in macrophages engenders a broad anti-inﬂammatory proﬁle in
these cells under the pro-inﬂammatory stress conditions of LPS
treatment.
Recently it has been found that macrophages from aged mice display
an inﬂammatory phenotype and an associated increased ability to
lower WAT catecholamine levels due to a GDF3-dependent up-
regulation of the catecholamine degradation machinery [19]. Consis-
tent with these ﬁndings, relative Gdf3 expression was signiﬁcantly
reduced in both untreated and LPS-treated Irs2LyzM/ BMDM
compared to control BMDM. (Figure 4D). However, when we examined
expression of the machinery for bioamine uptake, we did not detect
Slc6a2, the noradrenaline transporter (Supplemental Table 2), which is
consistent with recent ﬁndings [20] and suggest this is exclusively
expressed in SAMs. In addition, we examined the expression of a
number of genes involved in bioamine metabolism such as Maoa,
Comt, and members of the Aldh and Akr families of enzymes involved
in biogenic enzyme degradation. Although Maoa expression was
reduced in LPS-treated Irs2LyzM/ BMDM, in general there was no
concerted change in the expression pattern of these genes that would
explain the increase in WAT catecholamine levels via effects upon
macrophage-clearance of catecholamines (Supplemental Table 2).
Deletion ofMecp2, a nuclear transcriptional regulator implicated in Rett
syndrome, in the BAT-resident CX3CR1-expressing macrophage
population recently has been shown to reduce BAT sympathetic
innervation [45]. In contrast, we demonstrate increased TH-positive
nerve ﬁbre density in this tissue in Irs2LyzM/ mice. Together these
ﬁndings indicate that intrinsic macrophage signaling events might
regulate pathways directly involved in nerve growth and maintenance.
Consistent with this idea, in untreated Irs2LyzM/ BMDM we found
increases in the expression of genes in GO categories including pos-
itive regulation of neuron development, synapse assembly and neuron
projection (Figure 4E). In Irs2LyzM/ BMDM treated with IL4 we found
increased expression in GO categories including regulation of neuron
projection development and positive regulation of axon extension and
axon regeneration (Figure 4E). In LPS-treated Irs2LyzM/ BMDM, we
found increased expression in GO categories including positive regu-
lation of neuron projection and axon extension and remodeling
(Figure 4E). While these categories included genes classically
expressed in neurons they also included genes for secreted proteins
and cell surface proteins involved in cell adhesion and cell-to-cell in-
teractions processes through which macrophages could potentially
directly be involved in the regulation of neuronal function. The genes in
the GO categories involved included: L1cam, a cell adhesion molecule
involved in neurite outgrowth [57]; Serpine2, which promotes neurite
extension [58]; Sdc4, which plays a role in neuron adhesion processes
[59]; Flrt3, which is involved in axon guidance [60]; Flt1, which has
neurotrophic effects [61]; Pvrl1, an adhesion molecule with roles in
gliaeneuron interactions [62]; Tgfb1, which is involved in a number of
elements of neuronal function [63]; Sema4d, a semaphorin that acts a
soluble neurotrophic factor [64]; Megf8, a transmembrane EGF-like
protein implicated in neural growth [65] and Nrg1, a nerve growth
factor [66] (Figure 4F). Gene expression categories related to cell
adhesion and to vascular development, which may also be involved in
the control of tissue innervation [67], were also upregulated in
Irs2LyzM/ BMDM (Figure 4G). Together these ﬁndings suggest that
deletion of Irs2 in macrophages potentially creates an environment in
BAT that enhances sympathetic innervation.MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier GmbH. This is an o
www.molecularmetabolism.comInterestingly, we also found an increase in the expression of microglial
markers in IL4 treated Irs2LyzM/ BMDM including Cx3cr1 (Figure 4H
[68,69]), suggesting that there could be an increased association of
these cells with nerves although we did not detect increased macro-
phage numbers in adipose tissue. Furthermore, we note that Irs2 is
enriched in SAMs compared to other macrophage populations [20]
again suggesting a role for this signaling molecule in these cells. We
also found a signiﬁcant increase in the expression of the b2 adrenergic
receptor (Adrb2) and a non-signiﬁcant increase in the b adrenergic
receptor kinase 2 (Adrbk2) in IL4-treated Irs2LyzM/ BMDM (Figure 4I).
Together these expression proﬁles suggest that macrophages may play
a positive role in tissue nerve function and that deletion of Irs2 in-
creases the expression of such pathways indicating potential bidirec-
tional interplay between macrophages and sympathetic nerves.
3.6. Irs2 expression in BMDM is increased by palmitate and
deletion of Irs2 in macrophages attenuates insulin signaling but
paradoxically enhances IL4 signaling
Next, we further explored potential mechanisms underlying the above
gene expression proﬁles showing reduced inﬂammatory response to
LPS but a paradoxically preserved response to IL4 in Irs2LyzM/
BMDM. Insulin signaling in macrophages has been suggested to be
pro-inﬂammatory indicating that Irs2 might mediate such events and
that macrophage IRS2 may be involved in the detrimental effects of
inﬂammatory macrophages upon insulin action in other tissues.
Palmitate treatment induces an inﬂammatory state in BMDM and
conditioned medium from these cells induces insulin resistance in
muscle cells [70]. Consistent with this idea incubation of BMDM was
associated with an increase in Irs2 expression (Supplemental
Fig. 1E). Recent studies in BMDM from mice with global deletion of
Irs2 have demonstrated enhanced IL4-dependent M2 marker
expression, thought to be due to increased signaling via IRS1 [29]. As
described above, we also found preservation and in some cases
enhancement of IL4-stimulated gene expression in Irs2LyzM/
BMDM. However, we found minimal expression of Irs1 and Irs3 and
no Irs4 mRNA in wild type BMDM consistent with previous ﬁndings
that Irs2 is the predominant Irs gene in hematopoetic cells [24e26
and Supplemental Table 2], and we saw no change in expression of
Irs1 or Irs3 mRNA upon Irs2 deletion in our RNAseq data (Irs1: 0.12
log2FC; P ¼ 0.91 and Irs3: 0.11 log2FC; P ¼ 0.89). Indeed, we could
not detect IRS1 protein expression in these cells by western blotting
(Supplemental Fig. 1F). However, in Irs2LyzM/ BMDM, we found
increased AKT phosphorylation in response to IL4 treatment
(Supplemental Fig. 1G). This was consistent with recent studies [29]
despite attenuation of insulin-stimulated AKT phosphorylation
(Supplemental Fig. 1H), indicating that normally IRS2 signaling in part
plays a role in restraining IL4 signaling or that loss of IRS2 allows an
alternative signaling pathway to be engaged that mediates effects
upon gene expression driven by IL4.
4. DISCUSSION
There is increasing recognition that the interplay between the immune
and nervous systems plays a key role in the regulation of adipose
tissue function [71]. In the current studies, we demonstrate that
deletion in LyzM-expressing macrophage populations of Irs2, a major
mediator of IL4 and insulin signaling, leads to resistance to diet-
induced obesity via increased BAT thermogenesis through increased
sympathetic innervation and increased local catecholamine availability.
Underpinning these observations, we ﬁnd that Irs2-deﬁcient BMDMpen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 9
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MOLMET749_proof ■ 3 December 2018 ■ 10/13do not express catecholamine biosynthetic machinery but, when
challenged with an inﬂammatory stimulus, display a transcriptional
proﬁle consistent with reduced inﬂammation together with alterations
in the expression of genes that are involved in the regulation of tissue
innervation, sympathetic nerve function, and adipose tissue lipolysis.
Our studies therefore links insulin and IL4 signaling through IRS2 in
macrophages to the regulation of systemic metabolism via control of
adipose tissue sympathetic nerve function, adding new insights to the
signaling processes involved in this neuroeimmune interaction.
Previously, a series of studies has suggested that AAM produce cat-
echolamines in an IL4-dependent manner to regulate BAT and WAT
thermogenic programs and adipocyte metabolism [17]. In this work,
mice with myeloid-restricted deletion of Il4ra displayed impaired M2
polarization and defective cold adaptive thermogenesis associated with
a reduced production of catecholamines by macrophages [17]. How-
ever, recent evidence has challenged this model with a failure to detect
either catecholamine biosynthetic apparatus in adipose tissue mac-
rophages or beneﬁcial effects of chronic IL4 treatment upon energy
expenditure [18,20]. While we found both increased BAT browning and
an associated increase in adipose tissue noradrenaline levels in our
mutant mice, we did not detect the machinery for catecholamine
synthesis in BMDM or noradrenaline in BMDM conditioned medium at
levels above that seen in medium alone. Recent studies have also
suggested that macrophages per se are not the source of catechol-
amines in adipose tissue [18,20,72], although another recent paper
has demonstrated Th expression in ATM [73]. Although our studies are
consistent with the idea that macrophages in adipose tissue may not
produce catecholamines, as we have performed many studies on
BMDM rather than ATM our work is cannot be deﬁnitive about this
issue as resident macrophages in tissues may display distinct phe-
notypes from BMDM [74]. Future work will be required to address this
speciﬁc question in Irs2LyzM/mice.
Our studies do suggest, however, that alterations in insulin and IL4
signaling may impact upon macrophage biology to engender changes
in adipose tissue function via sympathetic innervation. These obser-
vations are complicated by our ﬁndings that deletion of Irs2 in mac-
rophages causes polarization towards an anti-inﬂammatory phenotype
with persistent rather than attenuated signaling downstream of IL4.
This is consistent with recent ﬁndings in macrophages from mice with
global deletion of Irs2 which also displayed a paradoxical enhancement
of IL4 signaling [29] although, in our case, we did not detect upre-
gulation of Irs1 expression in Irs2-deﬁcient macrophages. It therefore
remains to be seen what mediates the preserved IL4 signaling in Irs2-
deﬁcient macrophages in our mouse model, with other adaptor mol-
ecules downstream of IL4 receptor signaling potentially playing a role.
Irs2 loss has been shown to cause enhanced rather than attenuated
functional end-points, including enhanced learning and memory [75].
This in turn leads to positive effects on physiology, suggesting that in
certain circumstances IRS2 may act as a brake upon speciﬁc signaling
processes [75].
Taken together, our data illustrate that altered insulin and IL4 signaling
in macrophages can have beneﬁcial metabolic effects acting via al-
terations in sympathetic nerve function rather than release of cate-
cholamines by macrophages per se. Recent studies have also revealed
potential alternative mechanisms by which this macrophage-mediated
regulation of adipose tissue sympathetic nerve function occurs. These
include the scavenging and catabolism of catecholamines or the direct
control of adipose tissue sympathetic innervation [19,20,45]. For
example, it has been demonstrated that a GDF3-dependent10 MOLECULAR METABOLISM xxx (xxxx) xxx  2018 The Authors. Published by Elsevier Gmechanism mediates the reduction of catecholamine-induced lipolysis
that occurs with ageing [19]. This study showed that age-related
NLRP3 inﬂammasome activation increased the ability of macro-
phages to scavenge catecholamines in adipose tissue with elevated
expression of MAOA occurring via GDF3, thereby resulting in reduced
adipose tissue lipolysis [19]. Consistent with these ﬁndings we show
that Irs2-deﬁcient BMDM have reduced expression of Gdf3 which
would potentially result in increased adipose tissue catecholamine
availability, although it should be noted that we have not studied gene
expression in ATMs per se. A parallel ﬁnding has been the identiﬁ-
cation of a specialized myeloid sub-population that is associated with
sympathetic nerves [20]. These SAMS scavenge catecholamines via
SLC6A2-dependent uptake and MAOA degradation pathways and
abrogation of SAM function leads to increased BAT recruitment and
WAT browning suggesting they may have a role in regulating adiposity
[20]. While we have not isolated SAMs, we ﬁnd that elements of the
catecholamine scavenging machinery are expressed in BMDM
(although not Slc6a2) although we do not detect concerted alterations
of these genes upon Irs2 deletion in these cells that might reduce
macrophage uptake and clearance of catecholamines. We also ﬁnd
that macrophages can be associated with BAT sympathetic nerves
consistent with the ﬁndings of others and demonstrating the potential
for the direct regulation of sympathetic nerve function by macro-
phages. Interestingly, while it appears that SAMs have a pro-
inﬂammatory phenotype [20], macrophages lacking Irs2 have an
anti-inﬂammatory phenotype when challenged with LPS suggesting
that distinct mechanisms and myeloid populations may be involved.
However, it also appears that SAMs are enriched for Irs2-expression
and express LyzM [20] and so it is possible that altered SAM function
contributes to the phenotype seen in our mice.
While we appear to only have partial evidence for a mechanism that
might involve alterations in catecholamine scavenging by macro-
phages, we ﬁnd increased density of sympathetic nerves in BAT and a
series of transcriptional changes in BMDM that might underpin this
ﬁnding. These include up-regulation of genes not only in implicated in
speciﬁc components of neuronal function such as axon guidance and
development but also in processes such as vascularization and cell
adhesion, which may play more generic roles in tissue innervation.
That macrophages can directly interact with the processes involved in
regulating BAT sympathetic nerves has been illustrated recently in
mice with macrophage deletion of Mecp2 [45]. The underlying
mechanisms appear to involve semaphorin signaling cross-talk be-
tween macrophages and nerves and speciﬁcally macrophages
expressing CX3CR1 [45]. We do not ﬁnd directly equivalent gene
expression alterations in semaphorin pathways in Irs2LyzM/ BMDM,
but, interestingly, these cells were enriched for microglial markers
such as Cxc3r1 potentially, suggesting an increased propensity to
interact with nerves.
While our work and that of others suggest that adipose tissue mac-
rophages directly interact with sympathetic nerves to regulate cate-
cholamine tone in this tissue, there are several lines of evidence that
macrophages with an inﬂammatory proﬁle may impair the ability of
BAT to respond appropriately to thermogenic stimuli. For example,
in vitro studies and analysis of macrophages from mice under HFD
feeding shows that TNFA and IL1B directly suppress the expression of
UCP1 in both BAT and WAT [76,77]. Therefore, the markedly reduced
inﬂammatory proﬁle seen in Irs2LyzM/ BMDM could contribute to the
enhanced BAT activity through direct transcriptional effects on Ucp1
and other components of the thermogenic programme in addition tombH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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MOLMET749_proof ■ 3 December 2018 ■ 11/13indirect effects via adipose tissue sympathetic nerve function. Upre-
gulation of Irs2 by palmitate, a pro-inﬂammatory stimulus for BMDM
that leads to secretion of insulin resistance-causing factors from
macrophages, further supports the idea that deletion of Irs2 reduces
macrophage inﬂammation and that this may be involved in the
beneﬁcial metabolic effects including improved insulin sensitivity.
It should also be noted that the LyzM-Cre mouse utilized in our studies
deletes in other myeloid lineage cells. This includes neutrophils which
have also been implicated in the regulation of adipose tissue function
and obesity-related insulin resistance [7e9,78]. Therefore, a limitation
of our study is that the in vivo phenotypes reported could potentially
involve a contribution from the cell types distinct from macrophages in
which LyzM-Cre is expressed.
In summary our studies indicate that the of deletion of Irs2 in mac-
rophages has beneﬁcial metabolic effects stemming from increased
activity of BAT and browning of WAT depots at ambient temperatures
due to an underlying increase in adipose tissue catecholamine func-
tion. This in turn is due to pleiotropic effects upon macrophage function
including a markedly reduced inﬂammatory proﬁle, the expression of
genes that may be involved in catecholamine scavenging and the
development of an appropriate cellular environment for enhanced
adipose tissue sympathetic innervation. Consistent with recent studies
we show that macrophages do not produce catecholamines per se but
that alteration of a component of both IL4 and insulin signaling in the
LyzM population of macrophages can have profound effects on sys-
temic metabolism. Therefore, our work adds to the growing evidence
that neuroeimmune interactions play a central role in adipose tissue
biology and the pathophysiology of obesity and insulin resistance while
identifying potential new cellular and molecular events to target for
therapeutic beneﬁt in these conditions.
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